80 related articles for article (PubMed ID: 35883062)
1. SARS-CoV-2 in a tropical area of Colombia, a remarkable conversion of presymptomatic to symptomatic people impacts public health.
Martínez C; Serrano-Coll H; Faccini Á; Contreras V; Galeano K; Botero Y; Herrera Y; Garcia A; Garay E; Rivero R; Contreras H; López Y; Guzmán C; Miranda J; Arrieta G; Mattar S
BMC Infect Dis; 2022 Jul; 22(1):644. PubMed ID: 35883062
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological and viral features of a cohort of SARS-CoV-2 symptomatic and asymptomatic individuals in an area of the Colombian Caribbean.
Mattar S; Martinez-Bravo C; Rivero R; Contreras H; Faccini-Martínez ÁA; Guzman-Teran C; Galeano K; Alvis-Guzman N; Contreras V; Arrieta G; Gonzalez-Tous M; Miranda J; Ospina M; Camargo-Assis F; Mercado-Reyes M; Garay E; Garcia-Perez A; Lopez Y; Tique V
Ann Clin Microbiol Antimicrob; 2020 Dec; 19(1):58. PubMed ID: 33287846
[TBL] [Abstract][Full Text] [Related]
3. Dynamic and features of SARS-CoV-2 infection in Gabon.
Mveang Nzoghe A; Padzys GS; Maloupazoa Siawaya AC; Kandet Yattara M; Leboueny M; Avome Houechenou RM; Bongho EC; Mba-Mezeme C; Mvoundza Ndjindji O; Biteghe-Bi-Essone JC; Boulende A; Essone PN; Ndong Sima CAA; Minkobame U; Zang Eyi C; Ndeboko B; Voloc A; Meye JF; Ategbo S; Djoba Siawaya JF
Sci Rep; 2021 May; 11(1):9672. PubMed ID: 33958601
[TBL] [Abstract][Full Text] [Related]
4. Symptomatic, Presymptomatic, and Asymptomatic Transmission of SARS-CoV-2 in a University Student Population, August-November 2020.
Krieg SJ; Schnur JJ; Miranda ML; Pfrender ME; Chawla NV
Public Health Rep; 2022; 137(5):1023-1030. PubMed ID: 35848117
[TBL] [Abstract][Full Text] [Related]
5. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: Update of a living systematic review and meta-analysis.
Buitrago-Garcia D; Ipekci AM; Heron L; Imeri H; Araujo-Chaveron L; Arevalo-Rodriguez I; Ciapponi A; Cevik M; Hauser A; Alam MI; Meili K; Meyerowitz EA; Prajapati N; Qiu X; Richterman A; Robles-Rodriguez WG; Thapa S; Zhelyazkov I; Salanti G; Low N
PLoS Med; 2022 May; 19(5):e1003987. PubMed ID: 35617363
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 in eight municipalities of the Colombian tropics: high immunity, clinical and sociodemographic outcomes.
Garay E; Serrano-Coll H; Rivero R; Gastelbondo B; Faccini-Martínez Á; Berrocal J; Pérez A; Badillo M; Martínez-Bravo C; Botero Y; Arrieta G; Calderón A; Galeano K; López Y; Miranda J; Guzmán C; Contreras V; Arosemena A; Contreras H; Brango-Tarra E; Oviedo M; Mattar S
Trans R Soc Trop Med Hyg; 2022 Feb; 116(2):139-147. PubMed ID: 34185868
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
8. Clinical Course and Molecular Viral Shedding Among Asymptomatic and Symptomatic Patients With SARS-CoV-2 Infection in a Community Treatment Center in the Republic of Korea.
Lee S; Kim T; Lee E; Lee C; Kim H; Rhee H; Park SY; Son HJ; Yu S; Park JW; Choo EJ; Park S; Loeb M; Kim TH
JAMA Intern Med; 2020 Nov; 180(11):1447-1452. PubMed ID: 32780793
[TBL] [Abstract][Full Text] [Related]
9. [Transmission of SARS-CoV-2 through contact with a SARS-CoV-2-infected individual in the presymptomatic or asymptomatic state in Japan: A case series].
Tanaka H; Ogata T; Morisada K; Tanaka S; Yoshida T; Nakanishi H; Misawa A; Nishida T; Tetsu O; Nagata M; Nakazato E
Nihon Koshu Eisei Zasshi; 2021 Aug; 68(8):550-558. PubMed ID: 33994491
[TBL] [Abstract][Full Text] [Related]
10. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.
Dixon BE; Wools-Kaloustian KK; Fadel WF; Duszynski TJ; Yiannoutsos C; Halverson PK; Menachemi N
PLoS One; 2021; 16(3):e0241875. PubMed ID: 33760821
[TBL] [Abstract][Full Text] [Related]
11. Symptom-based early-stage differentiation between SARS-CoV-2 versus other respiratory tract infections-Upper Silesia pilot study.
Mika J; Tobiasz J; Zyla J; Papiez A; Bach M; Werner A; Kozielski M; Kania M; Gruca A; Piotrowski D; Sobala-Szczygieł B; Włostowska B; Foszner P; Sikora M; Polanska J; Jaroszewicz J
Sci Rep; 2021 Jun; 11(1):13580. PubMed ID: 34193945
[TBL] [Abstract][Full Text] [Related]
12. A cross-sectional community-based observational study of asymptomatic SARS-CoV-2 prevalence in the greater Indianapolis area.
Meyers KJ; Jones ME; Goetz IA; Botros FT; Knorr J; Manner DH; Woodward B
J Med Virol; 2020 Nov; 92(11):2874-2879. PubMed ID: 32543722
[TBL] [Abstract][Full Text] [Related]
13. Early cases of SARS-CoV-2 infection in Uganda: epidemiology and lessons learned from risk-based testing approaches - March-April 2020.
Migisha R; Kwesiga B; Mirembe BB; Amanya G; Kabwama SN; Kadobera D; Bulage L; Nsereko G; Wadunde I; Tindyebwa T; Lubwama B; Kagirita AA; Kayiwa JT; Lutwama JJ; Boore AL; Harris JR; Bosa HK; Ario AR
Global Health; 2020 Nov; 16(1):114. PubMed ID: 33239041
[TBL] [Abstract][Full Text] [Related]
14. Saliva samples for detection of SARS-CoV-2 in mildly symptomatic and asymptomatic patients.
Tutuncu EE; Ozgur D; Karamese M
J Med Virol; 2021 May; 93(5):2932-2937. PubMed ID: 33501645
[TBL] [Abstract][Full Text] [Related]
15. Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility.
Arons MM; Hatfield KM; Reddy SC; Kimball A; James A; Jacobs JR; Taylor J; Spicer K; Bardossy AC; Oakley LP; Tanwar S; Dyal JW; Harney J; Chisty Z; Bell JM; Methner M; Paul P; Carlson CM; McLaughlin HP; Thornburg N; Tong S; Tamin A; Tao Y; Uehara A; Harcourt J; Clark S; Brostrom-Smith C; Page LC; Kay M; Lewis J; Montgomery P; Stone ND; Clark TA; Honein MA; Duchin JS; Jernigan JA;
N Engl J Med; 2020 May; 382(22):2081-2090. PubMed ID: 32329971
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of COVID-19 in Mexico: Symptomatic profiles and presymptomatic people.
Fernández-Rojas MA; Luna-Ruiz Esparza MA; Campos-Romero A; Calva-Espinosa DY; Moreno-Camacho JL; Langle-Martínez AP; García-Gil A; Solís-González CJ; Canizalez-Román A; León-Sicairos N; Alcántar-Fernández J
Int J Infect Dis; 2021 Mar; 104():572-579. PubMed ID: 33434668
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 Transmission Among Healthcare Workers in Iran: An Urgent Need for Early Identification and Management.
Abdolsalehi MR; Mahmoudi S; Badv RS; Pourakbari B; Mirnia K; Mahmoudieh Y; Mamishi S
Infect Disord Drug Targets; 2022; 22(1):e100821195494. PubMed ID: 35135466
[TBL] [Abstract][Full Text] [Related]
18. Epidemiological feature, viral shedding, and antibody seroconversion among asymptomatic SARS-CoV-2 carriers and symptomatic/presymptomatic COVID-19 patients.
Chen Y; Li P; Ding Y; Liu M; Liu L; Yi B; Wu T; Dong H; Lao X; Ding K; Wang H; Zhang D; Tan X; Wang Z; Xu G; Cao G
J Infect Public Health; 2021 Jul; 14(7):845-851. PubMed ID: 34118734
[TBL] [Abstract][Full Text] [Related]
19. Upper respiratory viral load in asymptomatic individuals and mildly symptomatic patients with SARS-CoV-2 infection.
Ra SH; Lim JS; Kim GU; Kim MJ; Jung J; Kim SH
Thorax; 2021 Jan; 76(1):61-63. PubMed ID: 32963115
[TBL] [Abstract][Full Text] [Related]
20. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.
Dixon BE; Wools-Kaloustian K; Fadel WF; Duszynski TJ; Yiannoutsos C; Halverson PK; Menachemi N
medRxiv; 2020 Oct; ():. PubMed ID: 33106813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
